Chandra Gupta S, Nandan Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140:1955–67.

Article  CAS  PubMed  Google Scholar 

Zampetaki A, Albrecht A, Steinhofel K. Long non-coding RNA structure and function: is there a link? Front Physiol. 2018;9:1201.

Article  PubMed  PubMed Central  Google Scholar 

Hulshoff MS, Del Monte-Nieto G, Kovacic J, Krenning G. Non-coding RNA in endothelial-to-mesenchymal transition. Cardiovasc Res. 2019;115:1716–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Z, Jiang S, Shang J, Jiang Y, Dai Y, Xu B, et al. LncRNA: shedding light on mechanisms and opportunities in fibrosis and aging. Ageing Res Rev. 2019;52:17–31.

Article  CAS  PubMed  Google Scholar 

Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Zhang S, Huang M, Hu H, Xie Y. U1RNP/lncRNA/transcription cycle axis promotes tumorigenesis of hepatocellular carcinoma. Diagnostics. 2022;12:1133.

Article  PubMed  PubMed Central  Google Scholar 

Yoon JH, Byun H, Ivan C, Calin GA, Jung D, Lee S. lncRNAs UC.145 and PRKG1-AS1 determine the functional output of DKK1 in regulating the Wnt signaling pathway in gastric cancer. Cancers. 2022;14:2369.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Ma X, Bian X, Zhang C, Liu X, Liu Q. LINC00586 represses ASXL1 expression thus inducing epithelial-to-mesenchymal transition of colorectal cancer cells through LSD1-mediated H3K4me2 demethylation. Front Pharmacol. 2022;13:887822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akimoto M, Susa T, Okudaira N, Hisaki H, Iizuka M, Okinaga H, et al. A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts. J Biol Chem. 2022;298:102065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fletcher CE, Deng L, Orafidiya F, Yuan W, Lorentzen M, Cyran OW, et al. A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. Mol Cancer. 2022;21:82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao Q, Zhang X, Chen D. The emerging potentials of lncRNA DRAIC in human cancers. Front Oncol. 2022;12:867670.

Article  CAS  PubMed Central  Google Scholar 

Pan H, Ding Y, Jiang Y, Wang X, Rao J, Zhang X, et al. LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis. Cancer Cell Int. 2021;21:7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R, Barlev NA. Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. Cell Death Dis. 2021;12:17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan N, Fu H, Feng X, Chen Y, Wang J, Wu Y, et al. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Front Mol Biosci. 2022;9:941653.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18:206.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Zhang Q, Yang D, Xie F, Wang Z. The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer. Mol Ther Nucleic Acids. 2022;28:397–407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Rabiee N, Kumar AP, Sethi G, Zarrabi A, Wang Y. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. Drug Discov Today. 2022;27:2181–98.

Article  CAS  PubMed  Google Scholar 

Zhou L, Li H, Sun T, Wen X, Niu C, Li M, et al. HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance. Cancer Lett. 2022;548:215861.

Article  CAS  PubMed  Google Scholar 

Ayub ALP, Perestrelo BdO, Pessoa GC, Jasiulionis MG, Chapter 15 - Useful methods to study epigenetic marks: DNA methylation, histone modifications, chromatin structure, and noncoding RNAs. In: Jasiulionis MG, editor. Epigenetics and DNA damage. London: Academic Press; 2022. p. 283–310.

Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114:A160–7.

Article  PubMed  PubMed Central  Google Scholar 

Nombela P, Miguel-López B, Blanco S. The role of m(6)A, m(5)C and Ψ RNA modifications in cancer: novel therapeutic opportunities. Mol Cancer. 2021;20:18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo T, Gong C, Wu P, Battaglia-Hsu SF, Feng J, Liu P, et al. LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles. Cell Death Differ. 2020;27:2191–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma S, De Carvalho DD, Jeong S, Jones PA, Liang G. Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet. 2011;7:e1001286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022;11:45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cun Y, An S, Zheng H, Lan J, Chen W, Luo W. et al. Specific regulation of m(6)A by SRSF7 promotes the progression of glioblastoma. Genom Proteom Bioinform. 2021;21:707–28.

Article  Google Scholar 

An S, Huang W, Huang X, Cun Y, Cheng W, Sun X, et al. Integrative network analysis identifies cell-specific trans regulators of m6A. Nucleic Acids Res. 2020;48:1715–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dinescu S, Ignat S, Lazar AD, Constantin C, Neagu M, Costache M. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes. 2019;10:52.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Xie H, Ying Y, Chen D, Li J. Roles of N(6) -methyladenosine (m(6) A) RNA modifications in urological cancers. J Cell Mol Med. 2020;24:10302–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patil DP, Pickering BF, Jaffrey SR. Reading m(6)A in the transcriptome: m(6)A-binding proteins. Trends Cell Biol. 2018;28:113–27.

Article  CAS  PubMed  Google Scholar 

Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537:369–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Z, Xue S, Zhang M, Xu H, Hu X, Chen S, et al. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39:6906–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Momen-Heravi F, Wu X, He K. Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Dis. 2022;29:2012–26.

Article  PubMed  Google Scholar 

Yang X, Zhang S, He C, Xue P, Zhang L, He Z, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19:46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Yang X, Chen Z, Tian L, Jiang G, Chen F, et al. m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Mol Cancer. 2019;18:87.

Article  PubMed  PubMed Central  Google Scholar